Recruiting

Observational Study

Sponsor:

UCLA

Code:

NCT06213532

Conditions

Smoking Cessation

Cigarette Smoking-Related Carcinoma

Lung Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Smoking Cessation Intervention

Saliva Collection

Survey Administration

Study Details

Brief summary:

This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.

Conditions

Smoking Cessation

Cigarette Smoking-Related Carcinoma

Lung Carcinoma

Study ID

NCT06213532

Start date

Dec 3, 2024

Status verified date

Jun, 2026

Completion date

Nov 30, 2026

Anticipated

Primary completion date

Nov 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • English, Spanish and Cantonese speaking
  • Age >= 18 years old
  • Primary care patients at the University of California, San Francisco (UCSF) General Internal Medicine (GIM) clinics
  • Must be current smokers and/or candidates for Lung Cancer Screening (LCS).

Key Informant Interviews:

\- Must be working in one of the clinics participating in CONNECTing to LungCare.

Exclusion Criteria:

  • Not a current smoker

Study Design

Enrollment

152 participants

Anticipated

Allocation

Randomized

Intervention Model

Sequential

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

other: Beta testing (CONNECTing to LungCare, feedback)

Participants interact with the CONNECTing to LungCare intervention and provide feedback in support of intervention refinement.

experimental: Feasibility trial, Group I (CONNECTing to LungCare)

Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision-making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly.

active comparator: Feasibility trial, Group II (usual care)

Participants receive usual care from their provider at their primary care appointment.

Interventions

Smoking Cessation Intervention

Multimedia program administered either remotely or in person

Saliva Collection

Saliva samples will be collected from each participant

Survey Administration

Ancillary studies

Primary outcome measure

  • Recruitment rate [ Time Frame: Up to 1 year ]
  • Retention rates [ Time Frame: Up to 1 year ]
  • Adherence rates [ Time Frame: Up to 1 year ]
  • Overall time required to recruit to the target sample size (Feasibility Cohort) [ Time Frame: Up to 1 year ]
  • Number of eligible participants [ Time Frame: Up to 1 year ]

Central Contacts and Locations

Central contacts

Judith Walsh

(415) 502-0862lungcare@ucsf.edu

Locations

University of California, San Francisco

Recruiting

San Francisco, California, United States, 94143

Contacts

415-502-0862lungcare@ucsf.edu

877-827-3222cancertrials@ucsf.edu

Principal Investigator:

Judith Walsh-Cassidy, MD

More Information

Sponsor

University of California, San Francisco

Last update posted

Jun 15, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-06-15.